Dendritic spine dysgenesis in Rett syndrome
Frontiers in Neuroanatomy
10 Sept 2014
http://journal.frontiersin.org/Journal/10.3389/fnana.2014.00097/full
NNZ-2566 is mentioned on page 5 of 8.
The [1–3]IGF-1 analog glycyl-L-methylprolyl-L-glutamic acid(NNZ-2566; Neuren Pharmaceuticals) is in a Phase-2 clinical trial in RTT individuals.
Vid, page-15
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.61 |
Change
0.395(2.60%) |
Mkt cap ! $1.994B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $4.291M | 274.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1393 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.61 | 2189 | 34 |
View Market Depth
| Last trade - 14.57pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |